JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB79237

Anti-PRPF8/Prp8 antibody

5

(5 Reviews)

|

(20 Publications)

Rabbit Polyclonal PRPF8/Prp8 antibody. Suitable for IP, WB, IHC-P, ICC/IF and reacts with Human, Mouse samples. Cited in 20 publications.

View Alternative Names

PRPC8, PRPF8, Pre-mRNA-processing-splicing factor 8, 220 kDa U5 snRNP-specific protein, PRP8 homolog, Splicing factor Prp8, p220

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRPF8/Prp8 antibody (AB79237)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PRPF8/Prp8 antibody (AB79237)

IHC image of PRPF8/Prp8 staining in human colon carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab79237, 10μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

Immunocytochemistry/ Immunofluorescence - Anti-PRPF8/Prp8 antibody (AB79237)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-PRPF8/Prp8 antibody (AB79237)

ICC/IF image of ab79237 stained HeLa cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab79237, 1µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899, DyLight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 100% methanol fixed (5 min) Hek293, HepG2 and MCF7 cells at 1µg/ml, and in 4% PFA fixed (10 min) HeLa, Hek293, HepG2 and MCF7 cells at 1µg/ml.

Immunoprecipitation - Anti-PRPF8/Prp8 antibody (AB79237)
  • IP

Unknown

Immunoprecipitation - Anti-PRPF8/Prp8 antibody (AB79237)

PRPF8/Prp8 was immunoprecipitated using 0.5mg Hela whole cell extract, 5μg of Rabbit polyclonal to PRPF8/Prp8 and 50μl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, Hela whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40μl SDS loading buffer and incubated for 10min at 70oC; 10μl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab79237.
Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697).
Band : 250kDa; PRPF8/Prp8

All lanes:

Immunoprecipitation - Anti-PRPF8/Prp8 antibody (ab79237)

Predicted band size: 274 kDa

false

Western blot - Anti-PRPF8/Prp8 antibody (AB79237)
  • WB

Unknown

Western blot - Anti-PRPF8/Prp8 antibody (AB79237)

The 250 kDa band observed is comparable to the molecular weight seen with other commercially available antibodies to PRPF8/Prp8.

All lanes:

Western blot - Anti-PRPF8/Prp8 antibody (ab79237) at 1 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 2:

HeLa (Human epithelial carcinoma cell line) Nuclear Lysate at 10 µg

Lane 3:

NIH 3T3 (Mouse embryonic fibroblast cell line) Whole Cell Lysate at 10 µg

Lane 4:

A431 (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 5:

MEF1 (Mouse embryonic fibroblast cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 274 kDa

Observed band size: 250 kDa

true

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

ICC/IF, WB, IP, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "5 µg/mL", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "10 µg/mL", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Cow": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays a role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes, both of the predominant U2-type spliceosome and the minor U12-type spliceosome (PubMed : 10411133, PubMed : 11971955, PubMed : 28076346, PubMed : 28502770, PubMed : 28781166, PubMed : 29301961, PubMed : 29360106, PubMed : 29361316, PubMed : 30315277, PubMed : 30705154, PubMed : 30728453). Functions as a scaffold that mediates the ordered assembly of spliceosomal proteins and snRNAs. Required for the assembly of the U4/U6-U5 tri-snRNP complex, a building block of the spliceosome. Functions as a scaffold that positions spliceosomal U2, U5 and U6 snRNAs at splice sites on pre-mRNA substrates, so that splicing can occur. Interacts with both the 5' and the 3' splice site.
See full target information PRPF8

Publications (20)

Recent publications for all applications. Explore the full list and refine your search

Acta neuropathologica communications 13:142 PubMed40581690

2025

Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets.

Applications

Unspecified application

Species

Unspecified reactive species

Antonio C Fuentes-Fayos,Miguel E G-García,Teresa Sánchez-Medianero,John Apps,Álvaro Flores-Martínez,Ana S De la Rosa-Herencia,Ignacio Gil-Duque,Georg Otto,Eva Venegas-Moreno,Eugenio Cárdenas Ruiz-Valdepeñas,Aura D Herrera-Martínez,Juan Solivera,Manuel D Gahete,David A Cano,Rosa Ortega,Alfonso Soto-Moreno,María A Gálvez-Moreno,Juan Pedro Martínez-Barberá,Raúl M Luque

Cell discovery 10:96 PubMed39285160

2024

Targeting SNRNP200-induced splicing dysregulation offers an immunotherapy opportunity for glycolytic triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Wenxiao Yang,Luo Hong,Linwei Guo,Yunjin Wang,Xiangchen Han,Boyue Han,Zheng Xing,Guoliang Zhang,Hongxia Zhou,Chao Chen,Hong Ling,Zhimin Shao,Xin Hu

Nature communications 15:5237 PubMed38898005

2024

Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Victoria O Shender,Ksenia S Anufrieva,Polina V Shnaider,Georgij P Arapidi,Marat S Pavlyukov,Olga M Ivanova,Irina K Malyants,Grigory A Stepanov,Evgenii Zhuravlev,Rustam H Ziganshin,Ivan O Butenko,Olga N Bukato,Ksenia M Klimina,Vladimir A Veselovsky,Tatiana V Grigorieva,Sergey Y Malanin,Olga I Aleshikova,Andrey V Slonov,Nataliya A Babaeva,Lev A Ashrafyan,Elena Khomyakova,Evgeniy G Evtushenko,Maria M Lukina,Zixiang Wang,Artemiy S Silantiev,Anna A Nushtaeva,Daria D Kharlampieva,Vassili N Lazarev,Arseniy I Lashkin,Lorine K Arzumanyan,Irina Yu Petrushanko,Alexander A Makarov,Olga S Lebedeva,Alexandra N Bogomazova,Maria A Lagarkova,Vadim M Govorun

Molecular oncology 18:2524-2540 PubMed38790138

2024

Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets.

Applications

Unspecified application

Species

Unspecified reactive species

Emilia Alors-Pérez,Ricardo Blázquez-Encinas,María Trinidad Moreno-Montilla,Víctor García-Vioque,Juan Manuel Jiménez-Vacas,Andrea Mafficini,Iranzu González-Borja,Claudio Luchini,Juan M Sánchez-Hidalgo,Marina E Sánchez-Frías,Sergio Pedraza-Arevalo,Antonio Romero-Ruiz,Rita T Lawlor,Antonio Viúdez,Manuel D Gahete,Aldo Scarpa,Álvaro Arjona-Sánchez,Raúl M Luque,Alejandro Ibáñez-Costa,Justo P Castaño

Journal of translational medicine 21:879 PubMed38049848

2023

Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.

Applications

Unspecified application

Species

Unspecified reactive species

Ricardo Blázquez-Encinas,Víctor García-Vioque,Teresa Caro-Cuenca,María Trinidad Moreno-Montilla,Federica Mangili,Emilia Alors-Pérez,Sebastian Ventura,Aura D Herrera-Martínez,Paula Moreno-Casado,Marco A Calzado,Ángel Salvatierra,María A Gálvez-Moreno,Lynnette Fernandez-Cuesta,Matthieu Foll,Raúl M Luque,Nicolas Alcala,Sergio Pedraza-Arevalo,Alejandro Ibáñez-Costa,Justo P Castaño

Journal of cellular physiology 238:1909-1920 PubMed37357506

2023

PRPF8 controls alternative splicing of PIRH2 to modulate the p53 pathway and survival of human ESCs.

Applications

Unspecified application

Species

Unspecified reactive species

Yiyang Sun,Lingling Zhang,Zhuoqing Fang,Dingyu Liu,Min Shao,Yujie Liu,Bing Liao,Ying Jin

Life science alliance 6: PubMed37019475

2023

Retinitis pigmentosa-associated mutations in mouse Prpf8 cause misexpression of circRNAs and degeneration of cerebellar granule cells.

Applications

Unspecified application

Species

Unspecified reactive species

Michaela Krausová,Michaela Kreplová,Poulami Banik,Zuzana Cvačková,Jan Kubovčiak,Martin Modrák,Dagmar Zudová,Jiří Lindovský,Agnieszka Kubik-Zahorodna,Marcela Pálková,Michal Kolář,Jan Procházka,Radislav Sedláček,David Staněk

Experimental & molecular medicine 55:132-142 PubMed36609600

2023

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing.

Applications

Unspecified application

Species

Unspecified reactive species

Juan L López-Cánovas,Natalia Hermán-Sánchez,Mercedes Del Rio-Moreno,Antonio C Fuentes-Fayos,Araceli Lara-López,Marina E Sánchez-Frias,Víctor Amado,Rubén Ciria,Javier Briceño,Manuel de la Mata,Justo P Castaño,Manuel Rodriguez-Perálvarez,Raúl M Luque,Manuel D Gahete

International journal of molecular sciences 24: PubMed36614170

2022

Reovirus μ2 Protein Impairs Translation to Reduce U5 snRNP Protein Levels.

Applications

Unspecified application

Species

Unspecified reactive species

Simon Boudreault,Carole-Anne Martineau,Laurence Faucher-Giguère,Sherif Abou-Elela,Guy Lemay,Martin Bisaillon

Nucleic acids research 50:5263-5281 PubMed35489070

2022

Reovirus μ2 protein modulates host cell alternative splicing by reducing protein levels of U5 snRNP core components.

Applications

Unspecified application

Species

Unspecified reactive species

Simon Boudreault,Mathieu Durand,Carole-Anne Martineau,Jean-Pierre Perreault,Guy Lemay,Martin Bisaillon
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com